Dr. Ronald Aung-Din, MD is one of the countrys most highly rated doctors, specializing in neurology and neuropsychiatry. Dr. Aung-Din currently sees patients in Sarasota, Florida but has patients coming from all over the United States and abroad. Out of state patients may first be evaluated through TeleHealth but are later, if convenient, generally required to be seen face to face. Dr. Aung-Din practices General Neurology & Neuro-Psychiatry and sees the entire age range of patients from infancy to geriatric age. He is board-certified by the American Board of Psychiatry & Neurology and member, American Academy of Neurology. After obtaining Bachelor’s and Master’s degrees in engineering at Bucknell (Lewisburg, PA) and Cornell (Ithaca, NY) Universities, he worked for a period as a supervising engineer. He then attended Columbia University in New York City for Premedical studies, followed by Medical School at University of Texas Southwestern Medical School, Dallas, TX. Residencies in Neurology and Neurosurgery were at University of Florida, Gainesville, FL. Other studies included a Medical Student Fellowship in Cardiology at Radcliffe Infirmary, Oxford, England and Clinical Neurology Fellowship at National Hospital for Nervous Disease, Queen Square, London, UK. He has participated in over 60 pharmaceutical industry-sponsored clinical trials, functioning as Principal Investigator in drug research studies in MS, epilepsy, pain, Parkinson’s disease, and other neurological diseases. Dr. Aung-Din is also active in treating varied neurological and psychiatric conditions using delivery of CNS-active drugs with Neuro-DirectTM/Direct EffectsTM technology, developed by him for which 13 US and foreign patents have been granted; with others pending. Publications using this novel therapy in autism spectrum disorder, migraine, Parkinson’s disease, and diabetic neuropathy; in addition to articles on the use of cannabidiol, CBD, and the non-cannabis cannabinoid receptor agonist, caryophyllene, have appeared in Drug Development and Delivery and other peer-reviewed medical journals. Neuro-Direct TechnologyTM is unique in that therapeutic effect occurs through receptors on cutaneous free-nerve endings under the skin surface with direct afferent neural connections to the central nervous system, CNS. As such, the general circulation and blood-brain-barrier are bypassed, with avoidance of usual systemic side effects and drug interactions. AfGin Pharma, LLC was founded by Dr. Aung-Din in 2009 to advance this unique technology and its goal of “Enhanced Neuro-Therapeutics through Direct Effects Topical Technology.” website: aungdinmd.com.